FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 300:579-584 March 15, 1979 Number 11 Next

	Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited PubMed Citation

Abstract

To determine the implication of decreased T3 production during fasting, seven normal men were fasted for 80 hours on two occasions; they received 5 microgram of T3 every three hours durnig the second fast. The mean serum T3 concentration declined during the control fast from 120 to 73 ng per deciliter (P less than 0.01), but remained slightly above base-line values during the T3 fast. Mean serum T4 concentrations did not change, and mean serum rT3 concentrations increased, during both fasts. The peak serum TSH increment after TRH was 11.1 micromicron per milliliter before fasting, 8.9 (not significant) after the control fast and 2.2 (P less than 0.01) after the T3 fast. Urea excretion was 9.1 per cent higher during the T3 fast; there were no differences in the changes in blood glucose, plasma fatty acids or other substrates during the two fasts. Pretreatment with potassium iodide lowered serum T4 concentrations and increased the serum TSH response to TRH after fasting. We conclude that the decrease in serum T3 concentrations during fasting spares muscle protein. Fasting is accompanied by a lower set point of TSH secretion, which remains sensitive to changes in serum thyroid hormone concentrations.

This article has been cited by other articles:

• Bosy-Westphal, A., Kossel, E., Goele, K., Later, W., Hitze, B., Settler, U., Heller, M., Gluer, C.-C., Heymsfield, S. B, Muller, M. J (2009). Contribution of individual organ mass loss to weight loss-associated decline in resting energy expenditure. Am. J. Clin. Nutr. 90: 993-1001 [Abstract] [Full Text]  
• Kaptein, E. M., Beale, E., Chan, L. S. (2009). Thyroid Hormone Therapy for Obesity and Nonthyroidal Illnesses: A Systematic Review. J. Clin. Endocrinol. Metab. 94: 3663-3675 [Abstract] [Full Text]  
• Araujo, R. L., de Andrade, B. M., de Figueiredo, A. S. P., da Silva, M. L., Marassi, M. P., dos Santos Pereira, V., Bouskela, E., Carvalho, D. P (2008). Low replacement doses of thyroxine during food restriction restores type 1 deiodinase activity in rats and promotes body protein loss. J Endocrinol 198: 119-125 [Abstract] [Full Text]  
• Spratt, D. I., Frohnauer, M., Cyr-Alves, H., Kramer, R. S., Lucas, F. L., Morton, J. R., Cox, D. F., Becker, K., Devlin, J. T. (2007). Physiological effects of nonthyroidal illness syndrome in patients after cardiac surgery. Am. J. Physiol. Endocrinol. Metab. 293: E310-E315 [Abstract] [Full Text]  
• Siroen, M. P. C., van Bokhorst-de van der Schueren, M. A. E., Richir, M. C., Sauerwein, H. P., Leemans, C. R., Quak, J. J., van Leeuwen, P. A. M. (2006). The Prognostic Value of Severe Malnutrition in the Development of Nonthyroidal Illness in Head and Neck Cancer Patients. JPEN J Parenter Enteral Nutr 30: 415-420 [Abstract] [Full Text]  
• Palesty, J. A., Dudrick, S. J. (2006). The Goldilocks Paradigm of Starvation and Refeeding. Nutr Clin Pract 21: 147-154 [Full Text]  
• Onur, S., Haas, V., Bosy-Westphal, A., Hauer, M., Paul, T., Nutzinger, D., Klein, H., Muller, M. J (2005). L-Tri-iodothyronine is a major determinant of resting energy expenditure in underweight patients with anorexia nervosa and during weight gain. Eur J Endocrinol 152: 179-184 [Abstract] [Full Text]  
• Bianco, A. C., Salvatore, D., Gereben, B., Berry, M. J., Larsen, P. R. (2002). Biochemistry, Cellular and Molecular Biology, and Physiological Roles of the Iodothyronine Selenodeiodinases. Endocr. Rev. 23: 38-89 [Abstract] [Full Text]  
• Nørrelund, H., Nair, K. S., Jørgensen, J. O. L., Christiansen, J. S., Møller, N. (2001). The Protein-Retaining Effects of Growth Hormone During Fasting Involve Inhibition of Muscle-Protein Breakdown. Diabetes 50: 96-104 [Abstract] [Full Text]  
• De Groot, L. J. (1999). Dangerous Dogmas in Medicine: The Nonthyroidal Illness Syndrome. J. Clin. Endocrinol. Metab. 84: 151-164 [Full Text]  
• Van den Berghe, G., de Zegher, F., Bouillon, R. (1998). Acute and Prolonged Critical Illness as Different Neuroendocrine Paradigms. J. Clin. Endocrinol. Metab. 83: 1827-1834 [Full Text]  
• Legradi, G., Emerson, C. H., Ahima, R. S., Flier, J. S., Lechan, R. M. (1997). Leptin Prevents Fasting-Induced Suppression of Prothyrotropin-Releasing Hormone Messenger Ribonucleic Acid in Neurons of the Hypothalamic Paraventricular Nucleus. Endocrinology 138: 2569-2576 [Abstract] [Full Text]  
• Chopra, I. J. (1997). Euthyroid Sick Syndrome: Is It a Misnomer?. J. Clin. Endocrinol. Metab. 82: 329-334 [Full Text]  
• Utiger, R. D. (1995). Altered Thyroid Function in Nonthyroidal Illness and Surgery -- To Treat or Not to Treat?. NEJM 333: 1562-1563 [Full Text]  
• Reichlin, S. (1993). Neuroendocrine-Immune Interactions. NEJM 329: 1246-1253 [Full Text]  
• BORST, G. C., EIL, C., BURMAN, K. D. (1983). Euthyroid Hyperthyroxinemia. ANN INTERN MED 98: 366-378 [Abstract]  
• ENDOCRINOLOGY AND METABOLISM COMMITTEE, , MEDICAL KNOWLEDGE SELF-ASSESSMENT PROGRAM VI, , AMERICAN COLLEGE OF PHYSICIANS, (1982). Endocrinology and Metabolism: An Annotated Bibliography of Recent Literature: References to Journal Articles and Other Papers. ANN INTERN MED 97: 151-157 [Abstract]  
• WEINTRAUB, B. D., GERSHENGORN, M. C., KOURIDES, I. A., FEIN, H. (1981). Inappropriate Secretion of Thyroid-Stimulating Hormone. ANN INTERN MED 95: 339-351 [Abstract]